• G3 and Datavant today announced the formation of a strategic partnership to improve the design and interpretation of clinical trials
• Datavant and G3 will work closely together in engaging with biopharmaceutical partners and implementing innovative approaches to clinical trial design and interpretation, leveraging the power of their combined datasets and analytics capabilities
• G3 will provide Datavant with summary data to incorporate into Datavant's Clinical Trial Data Cloud, facilitating the identification of opportunities to integrate G3 into Datavant's engagements

Read the full article here: https://www.prnewswire.com/news-releases/global-genomics-group-and-datavant-announce-strategic-partnership-to-improve-design-and-interpretation-of-clinical-trials-300578061.html